Leqembi

2023 - 7 - 6

Post cover
Image courtesy of "The New York Times"

FDA Makes Alzheimer's Drug Leqembi Widely Accessible (The New York Times)

The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.

FDA Converts Novel Alzheimer's Disease Treatment to Traditional ... (FDA.gov)

The FDA converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer's Disease, to traditional approval following a determination ...

Post cover
Image courtesy of "PBS NewsHour"

Alzheimer's drug Leqembi has full FDA approval, clearing way for ... (PBS NewsHour)

The FDA gave it conditional approval in January based on early results suggesting the drug could modestly slow cognitive decline.

Post cover
Image courtesy of "USA TODAY"

Eisai and Biogen, Leqembi manufacturer, receive FDA approval for ... (USA TODAY)

The FDA approval includes a box label warning about the drug's known side effects, which include brain swelling and tiny bleeds. · Lecanemab is the first amyloid ...

Statement: Broader Medicare Coverage of Leqembi Available ... (CMS)

Broader Medicare coverage is now available for Biogen and Eisai's Leqembi (the brand name for lecanemab) following the Food and Drug Administration's (FDA) ...

Post cover
Image courtesy of "FiercePharma"

Eisai, Biogen snag full, traditional approval for Leqembi (FiercePharma)

Eisai and Biogen's new Alzheimer's disease med Leqembi has converted a speedy green light into a full-fledged, traditional approval at the FDA.

Post cover
Image courtesy of "Boston.com"

Biogen's Alzheimer's drug Leqembi has full FDA approval now ... (Boston.com)

The Food and Drug Administration endorsed the IV drug, Leqembi, for patients with mild dementia and other symptoms caused by early Alzheimer's disease. It's the ...

FDA fully approves Alzheimer's drug Leqembi (Becker's Hospital Review)

The FDA has granted full approval to Leqembi (lecanemab), a monoclonal antibody to treat patients with mild cognitive impairment or mild dementia stage of ...

Post cover
Image courtesy of "Spectrum News NY1"

FDA grants full approval to Alzheimer's drug Leqembi (Spectrum News NY1)

The decision clears the way for Medicare and other insurers to begin paying for the drug called Leqembi.

FDA Approval of Lecanemab (Leqembi) for Alzheimer's Disease ... (Public Citizen)

WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) today gave full approval to the drug lecanemab (Leqembi) to treat adults with Alzheimer's ...

Post cover
Image courtesy of "CBS News"

Leqembi, first Alzheimer's drug to slow disease, gets full FDA approval (CBS News)

Leqembi is not a cure, but it is the first drug shown to slow the progression of Alzheimer's disease. It first received an accelerated approval from the FDA ...

Post cover
Image courtesy of "Managed Healthcare Executive"

FDA Gives Alzheimer's Drug Leqembi Full Approval. That Means ... (Managed Healthcare Executive)

Medicare-eligible patients need to be enrolled in registry to get Medicare coverage for the anti-beta amyloid drug that is priced to cost $26500 a year.

Post cover
Image courtesy of "al.com"

Alzheimer drug Leqembi approved by FDA, covered by Medicare ... (al.com)

It's the first medicine that's been convincingly shown to modestly slow the cognitive decline caused by Alzheimer's.

Post cover
Image courtesy of "SDPB Radio"

Alzheimer's drug Leqembi gets full FDA approval. Medicare ... (SDPB Radio)

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

Post cover
Image courtesy of "NPR"

Alzheimer's drug Leqembi gets full FDA approval. Medicare ... (NPR)

Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow. July 6, 20234:48 PM ET. Heard ...

Alzheimer's drug Leqembi has full FDA approval now and that ... (Burlington Times News)

U.S. officials have granted full approval to a closely watched Alzheimer's drug for patients with early stages of the disease. The Food and Drug ...

The Risks and Benefits of Leqembi, the Newest Alzheimer's Drug ... (ConsumerReports.org)

Earlier this year, the Food and Drug Administration granted accelerated approval to lecanemab (Leqembi), the second treatment in a new category of ...

Explore the last week